| Dr Sanjay Mohan Ramchandani, MD | |
|
145 Hospital Ave, Suite 315, Du Bois, PA 15801-1462 | |
| (814) 371-6721 | |
| (814) 371-3921 |
| Full Name | Dr Sanjay Mohan Ramchandani |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 26 Years |
| Location | 145 Hospital Ave, Du Bois, Pennsylvania |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225009640 | NPI | - | NPPES |
| 369529 | Other | PA | MEDICARE PTAN |
| 151866402 | Medicaid | TX | |
| 10296982 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VM0101X | Obstetrics & Gynecology - Maternal & Fetal Medicine | L5107 (Texas) | Secondary |
| 207V00000X | Obstetrics & Gynecology | MD073392L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Winter Haven Hospital | Winter haven, FL | Hospital |
| Entity Name | Ob Hospitalist Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710647334 PECOS PAC ID: 5193866838 Enrollment ID: O20100104000363 |
News Archive
ValueOptions, Inc. a health improvement company specializing in mental and emotional well-being and recovery, and Genomind, a personalized medicine company, today announced an innovative study that uses pharmacogenomic testing to treat patients diagnosed with psychotic disorders, including schizophrenia and bipolar disorder.
Xencor, Inc., a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and cancer, today announced dosing the first patient in a Phase 2 trial of XmAb5871 in patients with IgG4-Related Disease (IgG4-RD).
Varian Medical Systems has received CE Mark for its latest ProBeam proton therapy system. The CE Mark allows Varian to begin installation of the newest version of its ProBeam system in the European Union.
Today, at the 52nd Annual Meeting of the American Association of Physicists in Medicine (AAPM) in Philadelphia, a group of researchers from Stanford University will describe the latest developments toward their goal of integrating two existing medical devices - medical linear accelerators, or "linacs," which produce powerful X-rays for treating cancer, and magnetic resonance imagers (MRIs), which are widely used to image tumors in the human body.
› Verified 1 days ago
| Entity Name | Premier Womens Care Ob/gyn Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235678756 PECOS PAC ID: 0547546178 Enrollment ID: O20170417000637 |
News Archive
ValueOptions, Inc. a health improvement company specializing in mental and emotional well-being and recovery, and Genomind, a personalized medicine company, today announced an innovative study that uses pharmacogenomic testing to treat patients diagnosed with psychotic disorders, including schizophrenia and bipolar disorder.
Xencor, Inc., a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and cancer, today announced dosing the first patient in a Phase 2 trial of XmAb5871 in patients with IgG4-Related Disease (IgG4-RD).
Varian Medical Systems has received CE Mark for its latest ProBeam proton therapy system. The CE Mark allows Varian to begin installation of the newest version of its ProBeam system in the European Union.
Today, at the 52nd Annual Meeting of the American Association of Physicists in Medicine (AAPM) in Philadelphia, a group of researchers from Stanford University will describe the latest developments toward their goal of integrating two existing medical devices - medical linear accelerators, or "linacs," which produce powerful X-rays for treating cancer, and magnetic resonance imagers (MRIs), which are widely used to image tumors in the human body.
› Verified 1 days ago
| Entity Name | Dhp Of Manatee Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134771611 PECOS PAC ID: 5799016846 Enrollment ID: O20191004000172 |
News Archive
ValueOptions, Inc. a health improvement company specializing in mental and emotional well-being and recovery, and Genomind, a personalized medicine company, today announced an innovative study that uses pharmacogenomic testing to treat patients diagnosed with psychotic disorders, including schizophrenia and bipolar disorder.
Xencor, Inc., a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and cancer, today announced dosing the first patient in a Phase 2 trial of XmAb5871 in patients with IgG4-Related Disease (IgG4-RD).
Varian Medical Systems has received CE Mark for its latest ProBeam proton therapy system. The CE Mark allows Varian to begin installation of the newest version of its ProBeam system in the European Union.
Today, at the 52nd Annual Meeting of the American Association of Physicists in Medicine (AAPM) in Philadelphia, a group of researchers from Stanford University will describe the latest developments toward their goal of integrating two existing medical devices - medical linear accelerators, or "linacs," which produce powerful X-rays for treating cancer, and magnetic resonance imagers (MRIs), which are widely used to image tumors in the human body.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sanjay Mohan Ramchandani, MD 145 Hospital Ave, Suite 315, Du Bois, PA 15801-1462 Ph: (814) 371-6721 | Dr Sanjay Mohan Ramchandani, MD 145 Hospital Ave, Suite 315, Du Bois, PA 15801-1462 Ph: (814) 371-6721 |
News Archive
ValueOptions, Inc. a health improvement company specializing in mental and emotional well-being and recovery, and Genomind, a personalized medicine company, today announced an innovative study that uses pharmacogenomic testing to treat patients diagnosed with psychotic disorders, including schizophrenia and bipolar disorder.
Xencor, Inc., a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and cancer, today announced dosing the first patient in a Phase 2 trial of XmAb5871 in patients with IgG4-Related Disease (IgG4-RD).
Varian Medical Systems has received CE Mark for its latest ProBeam proton therapy system. The CE Mark allows Varian to begin installation of the newest version of its ProBeam system in the European Union.
Today, at the 52nd Annual Meeting of the American Association of Physicists in Medicine (AAPM) in Philadelphia, a group of researchers from Stanford University will describe the latest developments toward their goal of integrating two existing medical devices - medical linear accelerators, or "linacs," which produce powerful X-rays for treating cancer, and magnetic resonance imagers (MRIs), which are widely used to image tumors in the human body.
› Verified 1 days ago
Mrs. Meike Schuster, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Ave, Du Bois, PA 15801 Phone: 814-371-2200 | |
Dr. Adolfo Rapaport, D.O. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 90 Beaver Dr, Suite 211d, Du Bois, PA 15801 Phone: 814-375-6000 Fax: 814-375-9503 | |
Dr. Ioanna Kanellitsas, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 145 Hospital Ave, Suite 315, Du Bois, PA 15801 Phone: 814-371-6172 Fax: 814-371-3921 |